EUVIMEDEUVIMED entdecken
Crossref

CTNNB1-Driven Tumors of the Testis and Ovary: A Unifying Concept

Kvetoslava Michalova, Andres M Acosta, Petr Martinek, Marian Grendar, Esther Oliva, Kyle Devins, Anais Malpica, John Kenneth Schoolmeester, Amy A Swanson, Deyin Xing, Jersy Lasota, Ankur Sangoi und 4 weitere

Modern Pathology · 2026-10 · 39 (10) · 101052

DOI: 10.1016/j.modpat.2026.101052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026-10. Verfasst von Kvetoslava Michalova und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic; Biopticka Laborator Ltd, Plzen, Czech Republic. Ele…. Hauptthemen laut MEDLINE: beta Catenin, Testicular Neoplasms, Ovarian Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several gonadal neoplasms harbor recurrent CTNNB1 mutations, including sex cord-stromal tumors, such as Sertoli cell tumors (not otherwise specified), gonadal signet ring stromal tumors, and ovarian and testicular microcystic stromal tumors (MCSTs), in addition to gonadal solid pseudopapillary neoplasms (SPNs). Despite being classified as separate entities, they have notable morphologic and immunophenotypic similarities. Of note, gonadal SPNs have been regarded as the counterparts of pancreatic SPNs, but their relationship remains poorly understood. We analyzed 32 gonadal CTNNB1-driven tumors, including testicular Sertoli cell tumors, NOS (n = 8), MCSTs (n = 2), and signet ring stromal tumors (n = 6), and ovarian MCSTs (n = 11), a signet ring stromal tumor (n = 1), and SPNs (n = 4), together with 9 pancreatic SPNs. Histologic features were reviewed, and immunohistochemistry for SF-1, SOX9, WT1, β-catenin, inhibin, and calretinin was performed. CTNNB1 mutation status was assessed by next-generation sequencing in selected cases. DNA methylation profiling was performed successfully in 25 (61%) tumors. All gonadal tumors showed overlapping morphologic features, comprising variable combinations of tubular, solid, signet ring, and microcystic patterns, although the abundance of individual patterns varied between entities. Pancreatic SPNs showed similar cytologic features to gonadal tumors and commonly exhibited solid and pseudopapillary architecture with frequent cystic structures but lacked true tubular differentiation. Immunohistochemically, SF-1 expression was present in 27 of 31 (87%) tested gonadal tumors, whereas all pancreatic SPNs were negative (4 of 4). Diffuse nuclear β-catenin expression was identified in all evaluable gonadal and pancreatic tumors (35 of 35; 100%). SOX9 and WT1 were expressed in 19 of 21 (90%) and 24 of 25 (96%) gonadal tumors, respectively. In contrast, pancreatic SPNs were negative for SF-1 and WT1 in all evaluable cases (4 of 4 each), with only a single case showing focal SOX9 positivity. Inhibin and calretinin expression was largely absent in gonadal tumors, with only rare focal or weak positivity (3 cases) and a single ovarian MCST showing diffuse calretinin expression. Methylation analysis demonstrated closely related epigenetic profiles among gonadal CTNNB1-driven tumors, regardless of their histologic classification, whereas pancreatic SPNs formed a separate cluster. These findings indicate that several CTNNB1-driven tumors of the gonads currently classified as different entities share morphologic, immunophenotypic, and epigenetic features, supporting the concept that they represent variations within the same spectrum. Despite some morphologic overlap, these gonadal tumors are different from pancreatic SPN based on DNA methylation signatures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta CateninTesticular NeoplasmsOvarian NeoplasmsBiomarkers, TumorSex Cord-Gonadal Stromal TumorsHumansMaleFemaleAdultMutationMiddle AgedDNA MethylationAdolescentYoung AdultAgedChildSertoli Cell TumorImmunohistochemistryChild, Preschool

Stichwörter der Autor:innen

CTNNB1mutationSertoli cell tumormethylationpancreassignet ringsolid pseudopapillary

Substanzen

beta CateninCTNNB1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic; Biopticka Laborator Ltd, Plzen, Czech Republic. Electronic address: kveta.michalova@biopticka.cz.
  • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
  • Biopticka Laborator Ltd, Plzen, Czech Republic.
  • Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic; Biopticka Laborator Ltd, Plzen, Czech Republic.
  • Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Förderung

  • Ministerstvo Zdravotnictví Ceské Republiky

Zitieren

APA

Michalova, K., Acosta, A. M., Martinek, P., Grendar, M., Oliva, E., Devins, K., Malpica, A., Schoolmeester, J. K., Swanson, A. A., Xing, D., Lasota, J., Sangoi, A., Dundr, P., Soukup, J., Ulbright, T. M., & Michal, M. (2026). CTNNB1-Driven Tumors of the Testis and Ovary: A Unifying Concept. Modern Pathology, 39(10), 101052. https://doi.org/10.1016/j.modpat.2026.101052

Vancouver

Michalova K, Acosta AM, Martinek P, Grendar M, Oliva E, Devins K, et al. CTNNB1-Driven Tumors of the Testis and Ovary: A Unifying Concept. Modern Pathology. 2026;39(10):101052. doi:10.1016/j.modpat.2026.101052

BibTeX
@article{Michalova2026,
  author = {Michalova, Kvetoslava and Acosta, Andres M and Martinek, Petr and Grendar, Marian and Oliva, Esther and Devins, Kyle and Malpica, Anais and Schoolmeester, John Kenneth and Swanson, Amy A and Xing, Deyin and Lasota, Jersy and Sangoi, Ankur and Dundr, Pavel and Soukup, Jiri and Ulbright, Thomas M and Michal, Michal},
  title = {CTNNB1-Driven Tumors of the Testis and Ovary: A Unifying Concept},
  journal = {Modern Pathology},
  year = {2026},
  volume = {39},
  number = {10},
  pages = {101052},
  doi = {10.1016/j.modpat.2026.101052}
}
Kostenlos starten →